Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow OSR Holdings, Inc.

Get SEC filing alerts via email and in your feed for OSR Holdings, Inc.

OSRH OSRHW

OSR Holdings, Inc.

About OSR Holdings, Inc.

OSR Holdings, Inc. is a global healthcare holding company operating through subsidiaries focused on developing innovative therapies and medical devices. Its core businesses include oral T-cell immunotherapies for cancer, design-augmented biologics for age-related degenerative diseases, and neurovascular intervention device distribution in Korea. OSR leverages scientific expertise and strategic partnerships to advance drug development and commercialization, targeting unmet medical needs with a diversified, risk-managed portfolio across major healthcare markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from OSR Holdings, Inc.

1
1
OSR Holdings, Inc. OSR Holdings Reports 36% Decline in Net Sales and Increased Operating Losses in Q1 2026

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
OSR Holdings, Inc. OSR Holdings Reports $27.06 Million Net Loss and Decreased Sales for 2025

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
OSR Holdings, Inc. OSR Holdings Reports Q3 2025 Financial Results with Net Loss of $3.19 Million

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
OSR Holdings, Inc. OSR Holdings Reports 29% Sales Increase but Faces Rising Costs and Operating Losses in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
OSR Holdings, Inc. OSR Holdings Reports 16% Decline in Net Sales and $11.4 Million Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
OSR Holdings, Inc. OSR Holdings Reports $15.9 Million Net Loss for Fiscal Year 2024 Amid Revenue Growth

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
OSR Holdings, Inc. Bellevue Life Sciences Acquisition Corp. Reports Significant Financial Changes in 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments